Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Health CareASX:RHC +1.85%80 Days Sales Outstanding is 50.73 as of Jun. 2026, which is 8% below its 10-year median of 55.35. GuruFocus rates ASX:RHC with a GF Score™ of 80/100 and a GF Value™ of A$40.76 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 56.04% on this metric.
The historical rank and industry rank for Ramsay Health Care's Days Sales Outstanding or its related term are showing as below:
ASX:RHC'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.87 Med: 55.35 Max: 59.5
Current: 51.22
During the past 13 years, Ramsay Health Care's highest Days Sales Outstanding was 59.50. The lowest was 44.87. And the median was 55.35.
ASX:RHC's Days Sales Outstanding is ranked worse than 56.04% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 45.825
vs ASX:RHC: 51.22
Ramsay Health Care's Days Sales Outstanding
increased
from Jun. 2025 (50.71) to Jun. 2026 (50.73).
Ramsay Health Care (ASX:RHC) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Ramsay Health Care Days Sales Outstanding Related Terms
Ramsay Health Care Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Ramsay Health Care's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:RHC vs HCA, THC, EHC: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Ramsay Health Care's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Health Care Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Ramsay Health Care's Days Sales Outstanding falls into.
Ramsay Health Care Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care (ASX:RHC) has a Days Sales Outstanding of 50.73 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ramsay Health Care and its competitors. This is near median its historical median of 55.35. Over the past decade, Ramsay Health Care's Days Sales Outstanding has ranged from 44.87 to 59.50. According to the industry distribution chart, Ramsay Health Care ranks #371 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 56%.
Is Ramsay Health Care's Days Sales Outstanding too high?
Ramsay Health Care's current Days Sales Outstanding of 50.73 is near median its 10-year median of 55.35. Over the past 10 years, this metric has ranged from a low of 44.87 to a high of 59.50. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.83. Ramsay Health Care's value of 50.73 is 10.7% above this industry median. Based on the distribution chart, Ramsay Health Care ranks #371 out of 662 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ramsay Health Care has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #371 out of 662 companies for Days Sales Outstanding. This places Ramsay Health Care in the lower half of its industry. The industry median Days Sales Outstanding is 45.83. Ramsay Health Care's value of 50.73 is 10.7% above this benchmark. Historically, Ramsay Health Care's own Days Sales Outstanding has ranged from 44.87 to 59.50 over the past decade. While the company's 10-year median is 55.35 vs. the industry median of 45.83, Ramsay Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.83, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Health Care's current Days Sales Outstanding of 50.73 is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ramsay Health Care and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current Days Sales Outstanding is 50.73, which is near median its own 10-year median of 55.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Overvalued. The stock's GF Value™ is A$40.76, compared to a current price of A$52.23 — trading 28.1% above its estimated fair value. The current Days Sales Outstanding is 50.73, which is near median its 10-year median of 55.35 and 10.7% above the Healthcare Providers & Services industry median of 45.83. Ramsay Health Care's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current Days Sales Outstanding is 50.73 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be overvalued.
The current stock price of A$52.23 is trading 28.1% above its estimated GF Value™ of A$40.76.
GuruFocus considers Ramsay Health Care to be Modestly Overvalued.
Key valuation signals for ASX:RHC:
Days Sales Outstanding: 50.73 (near median its 10-year median of 55.35)
GF Value™: A$40.76 vs. price of A$52.23 (28.1% above fair value)
Industry Position: 10.7% above the Healthcare Providers & Services median (#371 of 662)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
80GF Score
Get the complete analysis for ASX:RHC
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
